Diamines & Chemicals Ltd
Incorporated in 1976, Diamines and Chemicals Ltd is in the business of manufacturing and marketing of organic chemicals compounds[1]
- Market Cap ₹ 379 Cr.
- Current Price ₹ 390
- High / Low ₹ 693 / 305
- Stock P/E 139
- Book Value ₹ 165
- Dividend Yield 0.64 %
- ROCE 3.31 %
- ROE 1.76 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Earnings include an other income of Rs.3.18 Cr.
- Dividend payout has been low at 7.60% of profits over last 3 years
- Working capital days have increased from 125 days to 185 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|
66.86 | 57.40 | 43.94 | 39.09 | 35.58 | 62.82 | 65.97 | 110.34 | 103.97 | 71.47 | |
56.54 | 49.64 | 38.12 | 34.16 | 31.12 | 37.20 | 43.90 | 54.72 | 81.29 | 66.04 | |
Operating Profit | 10.32 | 7.76 | 5.82 | 4.93 | 4.46 | 25.62 | 22.07 | 55.62 | 22.68 | 5.43 |
OPM % | 15.44% | 13.52% | 13.25% | 12.61% | 12.54% | 40.78% | 33.45% | 50.41% | 21.81% | 7.60% |
0.38 | 0.23 | 0.30 | 0.18 | 0.36 | 2.05 | 1.79 | 2.65 | 2.56 | 3.18 | |
Interest | 3.59 | 3.81 | 3.26 | 3.41 | 2.75 | 0.08 | 0.09 | 0.14 | 0.20 | 0.34 |
Depreciation | 2.16 | 2.39 | 2.43 | 2.03 | 1.99 | 1.79 | 1.67 | 1.78 | 2.85 | 3.49 |
Profit before tax | 4.95 | 1.79 | 0.43 | -0.33 | 0.08 | 25.80 | 22.10 | 56.35 | 22.19 | 4.78 |
Tax % | 28.89% | 25.14% | 9.30% | 378.79% | -212.50% | 18.64% | 24.34% | 25.64% | 28.39% | 38.08% |
3.52 | 1.35 | 0.39 | -1.59 | 0.25 | 20.99 | 16.71 | 41.90 | 15.47 | 2.73 | |
EPS in Rs | 3.60 | 1.38 | 0.40 | -1.63 | 0.26 | 21.46 | 17.08 | 42.83 | 15.81 | 2.79 |
Dividend Payout % | 27.78% | 3.62% | 0.00% | 0.00% | 0.00% | 23.30% | 17.56% | 7.00% | 15.80% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 6% |
5 Years: | % |
3 Years: | 3% |
TTM: | -31% |
Compounded Profit Growth | |
---|---|
10 Years: | 14% |
5 Years: | % |
3 Years: | -45% |
TTM: | -82% |
Stock Price CAGR | |
---|---|
10 Years: | 31% |
5 Years: | 14% |
3 Years: | 10% |
1 Year: | -23% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 15% |
Last Year: | 2% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 |
Reserves | 23.57 | 24.25 | 24.54 | 22.75 | 23.00 | 75.20 | 90.41 | 124.74 | 138.33 | 151.48 |
26.34 | 19.53 | 19.75 | 20.10 | 15.56 | 0.30 | 0.00 | 0.00 | 0.00 | 0.03 | |
14.85 | 12.90 | 10.47 | 10.05 | 8.64 | 9.50 | 10.36 | 16.56 | 14.56 | 16.80 | |
Total Liabilities | 74.54 | 66.46 | 64.54 | 62.68 | 56.98 | 94.78 | 110.55 | 151.08 | 162.67 | 178.09 |
34.51 | 33.23 | 31.51 | 29.30 | 27.33 | 22.47 | 37.55 | 40.06 | 65.38 | 63.79 | |
CWIP | 1.13 | 1.51 | 1.17 | 1.17 | 1.20 | 0.15 | 1.88 | 21.39 | 0.83 | 2.26 |
Investments | 0.10 | 0.10 | 0.10 | 0.10 | 0.08 | 5.94 | 12.67 | 13.30 | 15.76 | 16.07 |
38.80 | 31.62 | 31.76 | 32.11 | 28.37 | 66.22 | 58.45 | 76.33 | 80.70 | 95.97 | |
Total Assets | 74.54 | 66.46 | 64.54 | 62.68 | 56.98 | 94.78 | 110.55 | 151.08 | 162.67 | 178.09 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|
-0.53 | 16.01 | 2.73 | 2.49 | 7.12 | 15.37 | 27.27 | 16.28 | 21.90 | -5.02 | |
-4.50 | -5.43 | 0.86 | 0.51 | 0.08 | -14.93 | -21.49 | -8.66 | -18.83 | 14.65 | |
4.72 | -10.61 | -3.61 | -3.06 | -7.29 | -3.69 | -5.28 | -6.01 | -3.13 | 9.75 | |
Net Cash Flow | -0.31 | -0.03 | -0.02 | -0.06 | -0.09 | -3.25 | 0.50 | 1.61 | -0.07 | 19.38 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 56.50 | 65.75 | 67.04 | 72.74 | 75.71 | 54.79 | 55.44 | 75.72 | 58.63 | 70.68 |
Inventory Days | 177.56 | 122.26 | 184.13 | 184.33 | 155.05 | 283.59 | 43.30 | 233.57 | 135.42 | 320.39 |
Days Payable | 71.12 | 58.50 | 66.67 | 52.30 | 34.46 | 64.90 | 44.80 | 104.92 | 40.49 | 88.82 |
Cash Conversion Cycle | 162.95 | 129.52 | 184.50 | 204.77 | 196.31 | 273.47 | 53.93 | 204.37 | 153.56 | 302.25 |
Working Capital Days | 99.25 | 79.04 | 109.73 | 129.79 | 115.20 | 104.35 | 39.61 | 96.39 | 94.37 | 184.52 |
ROCE % | 9.89% | 6.86% | 5.77% | 5.61% | 23.96% | 48.22% | 15.78% | 3.31% |
Documents
Announcements
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
30 May - Annual Secretarial Compliance Report 2024-25 confirms SEBI compliance; minor insider trading warnings issued.
-
Disclosure under Regulation 30A of LODR
29 May - Re-appointment of Executive Chairman and appointment of auditors for FY 2025-26 announced.
-
Audited Financial Results For The Quarter And Year Ended March 31, 2025, Net Worth Is 165.67 Crores
29 May - Approved FY25 audited results, 10% dividend, reappointed Executive Chairman, appointed auditors, updated policies.
-
Board Meeting Outcome for Outcome Of Board Meeting
29 May - Approved FY25 audited results, 10% final dividend, reappointed Executive Chairman, appointed new auditors for FY26.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
28 May - Copies of notices published in Business Standard and Vadodara Samachar on May 28, 2025 regarding transfer of shares of the company to IEPF.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
DCL is an ISO 9001:2015, ISO 9001:2015, ISO 14001:2015 & ISO 45001:2018, and DSIR-certified sole manufacturer of ethylene amines in India. It also manufactures Piperazine Anhydrous and Piperazine Solutions.